OmniAb logo

OmniAb

OABI | NASDAQ
Chart Builder DCF Calculator
$4.89
-$0.02 (-0.41%)
At close: Nov 16, 2026, 4:00 PM ET
$4.89
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.41%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
49.2
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #301/1021 (Top 29%)

Key Statistics

Market Data

Market Cap $713.26M
1D Range
4.73 4.94
52W Range
1.36 5.30

Valuation (TTM)

PE -14.38
PB 2.86
EV/EBITDA -25.97

Valuation (NTM)

Forward PE N/A
Forward PEG 0.33
Price Target $4.00
Loading financial charts...

Profile

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad s...

Sector Healthcare
Industry Biotechnology
Employees 89
IPO Date Sep 30, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Oct 30, 2026
EPS
-$0.12
Beat +5.62%
REV
$3.99M
Beat +14.34%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$4.00
Downside
-18.20%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.